Cyanidin-3-O-Glucoside improves the viability of human islet cells treated with amylin or Aβ1-42 in vitro.

Cyanidin-3-O-Glucoside improves the viability of human islet cells treated with amylin or Aβ1-42 in vitro.

Islet transplantation is being considered as an alternative treatment for type 1 diabetes. Despite recent progress, transplant recipients continue to experience progressive loss of insulin independence. Cyanidin-3-O-Glucoside (C3G) has shown to be protective against damage that may lead to post-tran...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jennifer Croden, Josue Rodrigues Silva, Wenlong Huang, Nancy Gupta, Wen Fu, Kaja Matovinovic, Mazzen Black, Xian Li, Kunsong Chen, Yulian Wu, Jack Jhamandas, Gina R Rayat
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/b9c73ac7b4974340bc4a9c3c8adefc23
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares